Ryan L. Boudreau, Ph.D.
Affiliations: | 2008 | University of Iowa, Iowa City, IA |
Area:
http://www.biomedexperts.com/Profile.bme/292624/Beverly_L_DavidsonGoogle:
"Ryan Boudreau"Mean distance: 17811
Parents
Sign in to add mentor| Beverly L. Davidson | grad student | 2008 | University of Iowa | |
| (Comparative analyses of hairpin-based RNA interference vectors for neurodegenerative disease therapy.) | ||||
BETA: Related publications
See more...
Publications
|
You can help our author matching system! If you notice any publications incorrectly attributed to this author, please sign in and mark matches as correct or incorrect. |
| Saad NY, Al-Kharsan M, Garwick-Coppens SE, et al. (2021) Human miRNA miR-675 inhibits DUX4 expression and may be exploited as a potential treatment for Facioscapulohumeral muscular dystrophy. Nature Communications. 12: 7128 |
| Zhang X, Yoon JY, Morley M, et al. (2018) A common variant alters SCN5A-miR-24 interaction and associates with heart failure mortality. The Journal of Clinical Investigation |
| Kim YC, Miller A, Lins LC, et al. (2017) RNA Interference of Human α-Synuclein in Mouse. Frontiers in Neurology. 8: 13 |
| Spengler RM, Zhang X, Cheng C, et al. (2016) Elucidation of transcriptome-wide microRNA binding sites in human cardiac tissues by Ago2 HITS-CLIP. Nucleic Acids Research |
| Piedrahita D, Castro-Alvarez JF, Boudreau RL, et al. (2015) β-Secretase 1's Targeting Reduces Hyperphosphorilated Tau, Implying Autophagy Actors in 3xTg-AD Mice. Frontiers in Cellular Neuroscience. 9: 498 |
| Madhavan L, Daley BF, Davidson BL, et al. (2015) Sonic Hedgehog Controls the Phenotypic Fate and Therapeutic Efficacy of Grafted Neural Precursor Cells in a Model of Nigrostriatal Neurodegeneration. Plos One. 10: e0137136 |
| Monteys AM, Wilson MJ, Boudreau RL, et al. (2015) Artificial miRNAs Targeting Mutant Huntingtin Show Preferential Silencing In Vitro and In Vivo. Molecular Therapy. Nucleic Acids. 4: e234 |
| Lee JH, Sowada MJ, Boudreau RL, et al. (2014) Rhes suppression enhances disease phenotypes in Huntington's disease mice. Journal of Huntington's Disease. 3: 65-71 |
| Ramachandran PS, Boudreau RL, Schaefer KA, et al. (2014) Nonallele specific silencing of ataxin-7 improves disease phenotypes in a mouse model of SCA7. Molecular Therapy : the Journal of the American Society of Gene Therapy. 22: 1635-42 |
| Ramachandran PS, Bhattarai S, Singh P, et al. (2014) RNA interference-based therapy for spinocerebellar ataxia type 7 retinal degeneration. Plos One. 9: e95362 |